Starling Oncology STLNW
NASDAQ STLNW
$0.04 -0.01 (-21.32%)
As of: Sep 9, 2026 · 12:49 PM EDT

Starling Oncology (STLNW) Operating Income Growth (5y) (2025 - 2026)

Analysis

Starling Oncology (STLNW) Operating Income Growth (5y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Davita 11.90 Bn 11.21 Bn 1.16 Bn
2 RadNet 5.50 Bn 4.77 Bn 88.08 Mn
3 Fresenius Medical Care AG 4.79 Bn 4.09 Bn 1.52 Bn
4 Concentra Group Holdings Parent 4.28 Bn 4.12 Bn 192.10 Mn
5 Privia Health 2.57 Bn 2.16 Bn -
6 Pediatrix Medical 2.15 Bn 1.75 Bn -
7 Progyny 2.11 Bn 1.87 Bn 89.30 Mn
8 Surgery Partners 1.85 Bn 1.63 Bn 622.10 Mn
9 U S Physical Therapy 1.18 Bn 1.15 Bn 41.94 Mn
10 Starling Oncology 4.13 Mn -36.96 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -32.84%
Mar 31, 2026 -30.02%
Dec 31, 2025 2.19%
Sep 30, 2025 -109.73%
Jun 30, 2025 -124.97%